ClinsChain GM, Yufeng Cao, was invited to participate 2018 ISPE-CCFDIE conference from Oct 16-18, 2018, and gave a presentation on CSM strategy and China practices. With the background of new regulation on clinical supply to be issued by CCFD, he shared with CCFD members and industry players his experiences and business cases of how to establish CSM quality system and operation processes to comply with the new regulation from clinical trial sponsors, or MAH’s perspectives. It was discussed about how to better support the construction of clinical supply regulations by the state, driving clinical supply operation to higher quality standard as well as the upgrading of the industry.
